Keiji AI
PrivateCompany Overview
Keiji AI is a technology company that provides an AI-native platform for clinical trial development, offering tools for protocol design, statistical programming, and regulatory reporting.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Biotechnology, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Keiji AI Comparables
Compare Keiji AI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kitsa | 89% | |
| Risklick AG | 84% | |
| Faro Health | 78% | |
Keiji AI Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 15, 2026
Grew 50% QoQ from 6 to 9 employees.
- Jul 20, 2025
Grew 300% QoQ from 1 to 4 employees.
Keiji AI Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Keiji AI's valuation, stock price, and market status.